The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Commensal Cross-Reactive T & B Cells Trigger Autoimmunity

Commensal Cross-Reactive T & B Cells Trigger Autoimmunity

October 26, 2020 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Dr. Kriegel thinks there is a need to look at both the human genome and microbiome. He says research should begin to identify a subset of individuals who have both genetic risk factors and autoimmunity-inducing bacteria.

You Might Also Like
  • Antibodies to Remicade Cross-React with Biosimilar Remsima
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
  • Gene Mutation Could Cause Gut Microbe Changes that Lead to RA
Also By This Author
  • H1N1 Influenza A Virus Brings Many Questions, Few Answers

“You really can’t easily change the genome, but you can consider a therapy that removes triggers in the microbiome,” he says. “Although no one has started to look closely at R. intestinalis, I think the microbiome adds to the triggers in autoimmunity, suggesting this [field] is a worthwhile area to work on translating to viable therapies.”

Dr. Alexander

Study ‘Thorough & Robust’
Jessy Alexander, PhD, research professor at Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, N.Y., says this research is a thorough and robust study addressing a novel aspect of the gut microbiome.

“The authors have carried out a detailed study using APS as their focus,” she says. “The unique feature is that they show a microbe that normally inhabits the human gut. R. intestinalis, can generate an immune response and trigger an autoimmune condition.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

β2GPI protein is important in clotting, and antibodies to this protein are present in APS patients. This work revealed a possible mechanism showing that R. intestinalis, closely mimics a cryptic antigen sequence of the β2GPI protein exposed after it is unfolded. When inhibited, the results include fetal loss and thromboembolism.

“Because this is a microbe normally present in the gut, clinicians may not give due importance as one of the possible culprits in APS,” says Dr. Alexander. “The microbial balance and homeostasis are important and should be followed with due diligence in APS and other autoimmune diseases.”


Kurt Ullman is a freelance writer based in Indiana.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Ruff WE, Dehner C, Kim WJ, et al. Pathogenic autoreactive T and B cells cross-react with mimotopes expressed by a common human gut commensal to trigger autoimmunity. Cell Host Microbe. 2019 Jul 10;26(1):100–113.e8. Epub 2019 Jun 18.

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: Antiphospholipid Antibody Syndrome (APS), Hughes Syndrome, Microbiome, microbiota

You Might Also Like:
  • Antibodies to Remicade Cross-React with Biosimilar Remsima
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
  • Gene Mutation Could Cause Gut Microbe Changes that Lead to RA
  • Alterations in the Microbiome Are Associated with Changes in Bone Quality

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)